Potential roles of mediator Complex Subunit 13 in Cardiac Diseases

Int J Biol Sci. 2021 Jan 1;17(1):328-338. doi: 10.7150/ijbs.52290. eCollection 2021.

Abstract

Mediator complex subunit 13 (MED13, previously known as THRAP1 and TRAP240) is a subunit of the cyclin-dependent kinase 8 (CDK8) kinase module in the eukaryotic mediator complex. MED13 has been known to play critical roles in cell cycle, development, and growth. The purpose of this review is to comprehensively discuss its newly identified potential roles in myocardial energy metabolism and non-metabolic cardiovascular diseases. Evidence indicates that cardiac MED13 mainly participates in the regulation of nuclear receptor signaling, which drives the transcription of genes involved in modulating cardiac and systemic energy homeostasis. MED13 is also associated with several pathological conditions, such as metabolic syndrome and thyroid disease-associated heart failure. Therefore, MED13 constitutes a potential therapeutic target for the regulation of metabolic disorders and other cardiovascular diseases.

Keywords: MED13; cardiovascular diseases; energy metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Heart Diseases / etiology
  • Heart Diseases / metabolism*
  • Humans
  • Mediator Complex / metabolism*
  • Oxidative Stress
  • Receptor Cross-Talk

Substances

  • MED12 protein, human
  • MED13 protein, human
  • Mediator Complex